INSTRUCTIONS FOR AUTHORS
PRS Global Open
Aims and Scope Statement for PRS Global Open
Plastic and Reconstructive Surgery—Global Open (PRS Global Open) is an open access, peer-reviewed, international journal focusing on global plastic and reconstructive surgery. PRS Global Open publishes on all areas of plastic and reconstructive surgery, including basic science/experimental studies pertinent to the field and also clinical articles on such topics as: breast reconstruction, head and neck surgery, pediatric and craniofacial surgery, hand and microsurgery, wound healing, and cosmetic and aesthetic surgery. Case reports, clinical studies, experimental articles, ideas and innovations, and techniques are all welcome article types.
Manuscript submission is open to all surgeons, researchers, and other health care providers world-wide who wish to communicate their research results on topics related to plastic and reconstructive surgery. Furthermore, PRS Global Open, a complimentary journal to Plastic and Reconstructive Surgery, provides an open-access venue for the publication of those research studies sponsored by private and public funding agencies that require open access publication of study results. Its mission is to disseminate high quality, peer-reviewed research in plastic and reconstructive surgery to the widest possible global audience, through an open access platform. As an open access journal, PRS Global Open offers its content for free to any viewer. Authors of articles retain their copyright to the materials published. Additionally, PRS Global Open provides rapid review and publication of accepted papers.
PRS Global Open serves the international plastic surgery community, including surgeons, care providers, and patients alike. We encourage international researchers to submit to the journal in order to advance patient safety, improve surgical and procedural outcomes, and elevate the science of plastic surgery worldwide. PRS Global Open serves the overall mission of the American Society of Plastic Surgeons®, owner of the journal: it educates and supports plastic surgeons globally to provide the highest quality patient care and maintain professional and ethical standards through education, research, and advocacy.
Indexing and Impact Factor
Plastic and Reconstructive Surgery – Global Open is indexed in Clarivate Analytics' Emerging Sources Citation Index, the required first step to achieving an Impact Factor. Journals indexed in the ESCI are regularly reviewed to be considered to receive an Impact Factor. Additionally, Plastic and Reconstructive Surgery – Global Open is indexed in PubMed Central, DOAJ, and Scopus.
About Open Access Publication
PRS Global Open is an open access journal. Distinct benefits and features of PRS Global Open include:
- Peer Review. A peer-reviewed publication, publishing selectively only those articles that pass peer review requirements of its Editorial Board.
- Electronic Delivery. Offer content via online and app-delivered publication modalities (no print option).
- Speed. Offer rapid review and publication times
- No “pay wall” for readers. Charge no subscription fees; are free and "open access" to any viewer
- Advertisements Welcome. Online advertising and commercial reprints are available.
- Front-End Funded. PRS Global Open, like most open access journals, generate their primary revenue through article processing charges paid either by individual authors, or authors' institutions/grant funding bodies
Article Processing Charges:
To provide open access to PRS Global Open content, the journal charges publication fees to the authors or other research sponsors/funding agencies for each article they publish. These fees cover numerous expenses incurred by publication, including the peer review process, journal production and publication, and hosting and archiving fees. Fees vary by article type and are excluding tax/VAT. Any required taxes/VAT will be applied during the payment process.
Please inquire with Editorial Office
Tier 5: Abstract (for meeting symposia)
Tier 4: Video
Tier 3: Letters/Replies; Viewpoints
Tier 2: Ideas & Innovations, Case Report
Tier 1: Original Articles, Special Topic, Follow-up Study
*Solicited Reply Letters to the Editor have no APC cost; the cost of the APC is included in the fee that the author of the Letter to the Editor paid.
Article Publication Charges (APCs) are charged after peer review and acceptance but prior to publication. All decisions to accept manuscripts are based solely on editorial criteria. Receipt of publication fees must be received by the publisher before an article is published. All fees and financial transactions related to article publication are conducted by the publisher, Wolters Kluwer.
Discounted APC Rate Eligibility:
PRS Global Open offers full or partial equitable waivers for accepted articles from low-income and middle-income economies. Eligibility is based on the Research4Life eligibility criteria. Countries listed in Group A are eligible for the full waiver and countries listed in Group B are eligible for the partial (50%) waiver. The waiver is automatically applied based on the Corresponding Author's country information provided during submission.
To determine your eligibility, visit the Research4Life criteria page at https://www.research4life.org/access/criteria/
At the time of submission to PRS Global Open, the "Region of Origin" selected by the corresponding author will determine eligibility to participate in this initiative. Eligible discounts will be applied automatically.
Open Access Copyright and License Information
PRS Global Open uses the Creative Commons License Attribution-NonCommercial No Derivative 4.0 License (CCBY-NC-ND) for all articles and content published. Use of the CCBY-NC-ND enables authors/creators of content to retain ownership of the copyright for their article/content and gives the American Society of Plastic Surgeons a license to publish the content. The CCBY-NC-ND agreement allows anyone to disseminate and reuse the article, as well as share and reuse of the scientific material, provided the original authors and original source (PRS Global Open reference) is given. Such downloading, use, reuse, etc. does not require permission from either the authors or the publisher. It does not allow commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license, visit: http://creativecommons.org/licenses/by-nc-nd/4.0.
Authors funded by RCUK, Wellcome Trust, Austrian Science Fund, World Bank, or the World Health Organization may publish open access using the Creative Commons Attribution License (CC-BY). Use of the CC-BY license enables authors/creators of content to retain ownership of the copyright for their article/content and gives the American Society of Plastic Surgeons a license to publish the content. The CC-BY agreement allows anyone to reuse the article and create derivatives, even for commercial purposes, provided the original authors and original source (PRS Global Open reference) is given. Such downloading, use, reuse, and derivative creation does not require permission from either the authors or the publisher. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0.
SUBMISSION OF MANUSCRIPTS
All new manuscripts need to be submitted on-line through Editorial Manager at: http://www.editorialmanager.com/gox/.
We recommend that all authors review the "Author Tutorial" located on the web site listed above. Authors must have an e-mail address at which they may be reached.
Relationship between PRS Global Open and PRS
Manuscripts may be submitted to PRS Global Open directly through the PRS Global Open Editorial Manager website: www.editorialmanager.com/gox. To do so, please follow the instructions below.
Furthermore, manuscripts submitted to Plastic and Reconstructive Surgery may be re-directed to PRS Global Open at the discretion of the Editor-in-Chief. Authors of manuscripts so re-directed from Plastic and Reconstructive Surgery will be contacted by the Editorial Office; authors have the right to permit transfer to PRS Global Open. If the authors agree, such papers will be transferred to the PRS Global Open review and publication processes.
Decisions concerning editing, revision, acceptance, or rejection of any manuscript are made by the Editor-in-Chief. These decisions may be based on the reviews of the associate editors and guest reviewers or may be at the Editor’s sole discretion. Editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format. Accepted articles may appear with an invited discussion if the Editor so desires.
Ethical Approval of Studies/Informed Consent:
Authors of manuscripts that describe experimental studies on either humans or animals must supply to the Editor a statement that the study was approved by an institutional review committee or ethics committee and that the subjects gave informed consent. Such approval should be described in the Methods section of the manuscript. Additionally, for studies conducted with human subjects, the method by which informed consent was obtained from the participants (i.e., verbal or written) also needs to be stated in the Methods section.
In those situations where a formal institutional review board process is not available, the authors must indicate that the principles outlined in the Declaration of Helsinki have been followed. More information regarding the Declaration of Helsinki can be found at https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
Registering Clinical Trials
PRS Global Open requires all articles reporting results of clinical trials to be registered in a public trials registry that is in conformity with the International Committee of Medical Journal Editors (ICMJE). All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. Phase I trials designed to study pharmacokinetics or major toxicity are exempt.
Manuscripts reporting on clinical trials (as defined above) should indicate that the trial is registered and include the registry information on a separate page, immediately following the author’s financial disclosure information. Required registry information includes trial registry name, registration identification number, and the URL for the registry.
Trials should be registered in one of the following trial registries:
(An updated list of WHO recognized Primary Registries which authors may use for registering their clinical trial) https://www.who.int/clinical-trials-registry-platform/network/primary-registries.
More information on registering clinical trials can be found in the article: Rohrich RJ, Longaker MT: Registering clinical trials in Plastic and Reconstructive Surgery. Plast. Reconstr. Surg 119(3): 1097, 2007.
Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal (in part or in full, in other words or in the same words, in English or in another language), and will not be submitted elsewhere unless rejected by the Journal or withdrawn by the author. Simultaneous submissions of the same article to multiple journals are prohibited.
Although there are occasional legitimate purposes for multiple manuscripts drawn from the same study, by and large this practice- also known as “Salami Slicing”- is a publishing ethics violation and is prohibited. If you feel that the broken up pieces of a single study have different hypotheses, populations, methods, etc, then you MUST cite all additional studies and discuss this openly in the cover letter and in the body of the manuscript itself. In general, we urge all authors to avoid inappropriately breaking up data from a single study into two or more papers.
Be transparent when submitting. Send copies of any closely-related manuscripts to the Editor-in-Chief. This includes any manuscripts that are being considered by another journal, published by another journal, or published by a preprint server or other entity.
If an author violates these requirements or engages in similar misconduct, the Journal's Editorial Board may reject the manuscript or impose a moratorium on acceptance of new manuscripts from the author. If it deems the misconduct sufficiently serious, the Editorial Board can refer the matter for investigation to the author's academic institution or hospital, to the appropriate state or local disciplinary body, and/or to the Ethics Committee of the American Society of Plastic Surgeons.
Manuscripts submitted to PRS Journals should not have been published previously in print or electronic format.
Public dissemination or posting of manuscripts prior to, simultaneous with, or after submission to this journal, such as posting the paper on preprint servers or other repositories, will require the Editor to make a determination of whether publishing this submitted manuscript will add sufficient new information to the medical literature or will be duplicative with information already published on the preprint server or similar medium. Given the Journals’ duplicate submission policy, if the preprint is found to be largely similar to the PRS Journals submission, the editors will decline the opportunity to consider the submission without prejudice. At the time of submission, authors should notify the Editor of any prior postings or publications (print or electronic) of this article. Authors must provide related active links to or copies of any preprint postings.
Successfully revising a manuscript does not guarantee acceptance.
The Editor-in-Chief maintains the right to submit accepted manuscripts to further reviews, revisions and possible change of status based on potential LEGAL, ETHICAL and BIOSTATISTICAL ISSUES which become evident prior to publication. This may result in the article being further revised or even withdrawn from publication entirely at any point during the publication process.
For more on Editorial, Legal, and Ethical Policies, click here.
NECESSARY FILES FOR ELECTRONIC SUBMISSION ON Editorial Manager
- Cover Letter
- Manuscript (see instructions that follow)
- Figure(s) (when appropriate)
- Table(s) (when appropriate)
- Patient Photographic Authorization and Release form (when appropriate) (available
as a download file from the site)
- Author forms (License to Publish)
- Any necessary Permission letters
Note: The above items should be prepared as separate files. Each file MUST contain a file extension (.doc, .tif, .eps).
- File formats appropriate for text and table submissions include: Word, WordPerfect, and RTF.
- File formats appropriate for figure submissions include: TIFF, EPS, and high-resolution JPEG.
ON-LINE MANUSCRIPT SUBMISSION
First-Time Users: Please click the Register button and enter the requested information. Upon successful registration, you will be sent an e-mail indicating your username and password. Print a copy of this information for future reference. NOTE: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not need to re-register, even if your status changes (that is, as an author or as a reviewer).
Authors are required to submit their manuscripts on-line through Editorial Manager at: http://www.editorialmanager.com/gox/. Manuscripts which do not conform to the following regulations may be returned to the author for correction before being sent for peer review and at any point in the editorial process.
PRS Global Open has the following article types from which to choose:
- Original Article
- Special Topic
- Ideas and Innovations
- Case Report
- Follow-up Study
Manuscript Length/Number of Figures
To enhance quality, readability and to be more competitive with other leading scientific journals, all manuscripts must now conform to the new word-count standards for article length, references, and limited number of figure pieces. Because the APC fee is designed to cover production costs based on the number of words and electronic ‘pages,’ these limits will have to be strictly enforced by the Editor-in-Chief and the Editorial Office.
Abstract/ Summary Words
Figure Pieces/ Tables
· Original Article
· Special topic
· Follow-up Study
Up to 15 minutes*
· Ideas & Innovations
· Case Reports
105 words (I&I)**
NA (Case Reports)
Up to 6 minutes*
· Letters/ Replies
Up to 6 minutes- SDC only
Up to 20 minutes*
- Original Articles and Special Topics/Comprehensive Reviews are limited to 3355 words, 20 figures pieces, 60 references, and 15 minutes of video (separated into no more than 4 video clips)
- Ideas & Innovations are limited to 1355 words total, 4 figure pieces, 10 references, and 6 minutes of video (separated into no more than 3 video clips)
- Case Reports are limited to 1250 words total, 4 figure pieces, 10 references, and 6 minutes of video (separated into no more than 3 video clips)
- Viewpoints and Letters to the Editor are limited to 500 words, 2 figure pieces, 5 references, and up to 6 minutes of video (as Supplemental Digital Content only)
- Solicited Reply Letters to the Editor are limited to 400 words, 5 references, 0 figure and tables, and 0 videos.
- Video articles are limited to 500 words, 5 references, and up to 20 minutes of video (separated into no more than 4 video clips). Additionally, Video article types have a 90-character limit on the Title.
For definition purposes, one figure containing a pre-op and a post-op counts as two figure pieces.
*Notes regarding video:
- Any video clip over 30 seconds in length must have English-language Narration or Subtitles
- Each video clip must be submitted under 100 MB in size and in MP4 formatting. More details below.
**Notes regarding “Takeaways:”
- PRS Global Open is now publishing a “Takeaways” side-bar with certain article types (Original Articles, Follow-up Study, Special Topics, and Ideas & Innovations). Please use the standardized template to submit your “Takeaways” statement using the following prompts and headers.
- This field is limited to 105 words, including the headers. This field may not be peer-reviewed, but will be copyedited. It WILL publish as part of your final article, visible to all readers.
- Question: What is the key problem or question your study is trying to solve?
- Findings: What did your study show, in brief? This should include a brief description of the study design and the essential significant findings.
- Meaning: Provide a one-sentence summary of your article to inform the average reader. This should be the “take home point” to the reader (i.e. the one sentence “elevator speech” on what someone should know or remember about this article).
- Please use this standardized template to create your Takeaways: https://links.lww.com/PRSGO/B761
Articles not meeting these standards will be returned to the author until corrected.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, illustrations, and tables.
Authors are also required to obtain written releases from patients whose photographs are submitted to the journal for publication if the patients can be identified. A standardized patient authorization form for the release of patient photographs may be obtained from the Editorial Office or on-line at: www.PRSGlobalOpen.com or at http://www.editorialmanager.com/gox/. If an author chooses to use his or her own version for patient authorization, the form must include permission to use photographs for all types of media including but not limited to the following: print, visual, electronic, or broadcast media. Also, details in text that might identify patients should be avoided unless essential for scientific purposes. If identification of patients is unavoidable, informed consents should be obtained.
All copy must be double-spaced, including text, footnotes, references, figure legends, and tables. Each manuscript page must be numbered clearly, with the numbering continuing throughout.
All references, figures, and tables must be numbered and must be cited in numerical order in the text. Citations of figures and tables show the printer where to place them in the text.
If a statistical analysis is done, explanation of the method used must be stated in the text preceding the results. Unusual or complex methods of analysis should be referenced. Most papers that include statistical analyses are evaluated by a biostatistician during the review process.
For an original article, the title page includes the complete title of the article (As per journal style, the recommended length of an article title should be no longer than 16 words, and preferably under 14); a separate list of authors' names spelled out with middle initials and highest academic degrees; a list indicating each author’s affiliations and city; a footnote listing meetings at which the paper has been presented; and a short running head (no more than 40 characters in length).
Definition of ‘author’/Excessive Authorship: According to the International Committee on Medical Journal Editors (ICMJE), an author is defined as one who has made substantive intellectual contribution to the development of a manuscript. The ICMJE guidelines state that “authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4.” Authors of PRS Global Open articles must meet all four criteria of authorship.
If more than 10 authors are listed for any given manuscript, it will be sent back to the Corresponding Author. Overage should be relocated to the “Acknowledgment” section of the manuscript. Special exceptions to this rule can be sought via special request to the Editor-in-Chief via the Editorial Office.
Post-submission Changes in Authorship: After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the Editor from the authors concerned. This letter must be signed by all authors on the paper.
Academic Degrees for Authors
Please limit the total number of academic degrees to a maximum of three (3).
Corresponding Author Contact Information Page
On the second page, the complete name and address of the corresponding author, or the author who is responsible for handling reprints, must appear. This information must include an e-mail address.
Statement of Financial Disclosures, Conflicts of Interest, and Products:
All sources of funds supporting the work and a statement of financial interests, if any, must be included for each author.
Each author must disclose at the time of submission any commercial associations or financial disclosures that might pose or create a real or perceived conflict of interest (COI) with information presented in the submitted manuscript. Such associations include, but are not limited to:
- Stock ownership
- Patent licensing arrangements
- Payments for conducting or publicizing a study described in the manuscript
- Equity interests
- Employee, Board Member, or Review Panel Member for company affiliated with, discussed in, or otherwise associated in the subject matter discussed
Each author must disclose all relationships/activities/interests, whether or not they are directly related to the content of the manuscript. Disclosure represents a commitment to transparency and does not necessarily indicate a bias. If in doubt about whether to list a relationship/activity/interest, it is preferable that it is listed.
All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.) should also be disclosed.
A list of all products, devices, drugs, etc., used in the manuscript must also be included.
Authors must also disclose any funding received for a work from any of the following organizations: National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), etc.
All manuscripts must include all of this information on the title page, gathered from ALL AUTHORS and presented in a comprehensive financial disclosure statement. This statement should closely match what EACH author discloses in the 36-month COI questionnaire emailed to them upon submission. The financial disclosure statement will be printed with the article if it is accepted for publication.
Please do not “editorialize” your COI statement (i.e., please only state the facts of your/your co-authors’ COI without drawing any conclusions). COI statements that include subjective commentary could be edited/modified at the Editor’s discretion.
Please be mindful of what information is publicly available and/or already reported to your professional association insofar as your conflicts of interest. Consider including these items in your financial disclosure statement. Readers and auditors may review these additional disclosures and compare them to what is reported in your manuscript.
- For those in the USA, we recommend you review openpayments.cms.gov.
- Authors who serve as committee members for the American Society of Plastic Surgeons (ASPS) can review their COI statements on www.plasticsurgery.org by navigating to “Committee Member COI Form” underneath the “Membership” tab.
Structured Abstract Page
Original articles must begin with a structured abstract. The length should be no more than 250 words and should include the headings: Background, Methods, Results, and Conclusions. We encourage potential authors to look at recent issues of the journal for examples of similar articles.
The body of the text must conform to acceptable English usage and syntax; the contents must be clear, accurate, coherent, and logical. Avoid using abbreviations unless they are so common that they are never spelled out. The Journal aims for optimal readability.
Following the references, figure legends and tables, with complete credit lines for material that has been published previously, must be listed on separate pages. All figure legends and tables must be double-spaced. Figures and tables must be cited in numerical order in the text.
Invited discussions of accepted manuscripts are frequently requested by the Editors. The preparation of discussions is the same as for original articles. The title page for a discussion includes the title of the original article and the words "Discussion by" followed by the author or authors of the discussion.
Case Reports and Ideas and Innovations must include a summary at the end.
Guidelines for Viewpoints
Viewpoints, pertaining to issues of general interest, are welcome, even if they are not related to items previously published. Viewpoints may present unique techniques, brief technology updates, technical notes, and so on. Viewpoints will be published on a space-available basis because they are typically less time sensitive than Letters and other types of articles. Please note the following criteria:
- Text—maximum of 500 words (not including references)
- References—maximum of five
- Authors—no more than five
- Figures/Tables—no more than two figures and/or table
Authors will be listed in the order in which they appear in the submission. Viewpoints should be submitted electronically via Editorial Manager, at www.editorialmanager.com/gox/. We strongly encourage authors to submit figures in color.
We reserve the right to edit Viewpoints to meet requirements of space and format. Any financial interests relevant to the content must be disclosed. Submission of a Viewpoint constitutes permission for the American Society of Plastic Surgeons and its licensees and assignees to publish it in PRS Global Open and in any other form or medium. The views, opinions, and conclusions expressed in the Viewpoints represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of PRS Global Open. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.
The style for references can be found at the Journal’s web site (www.PRSGlobalOpen.com) and Editorial Manager (www.editorialmanager.com/gox/).
GUIDELINES FOR LETTERS TO THE EDITOR
Letters to the Editor, discussing material recently published in the PRS Global Open, are welcome. We will only consider Letters to the Editor that are received within three full months of an article’s compendium publication. For example, a Letter to the Editor about an article published in the January compendium must be submitted by the end of March. Letters to the Editor may be published with a response from the authors of the article being discussed; a response will be solicited for nearly all Letters to the Editor, but a response is not required to publish the original Letter to the Editor. Solicited Reply Letters to the Editor have no APC cost; the cost of the APC is included in the fee that the author of the Letter to the Editor paid.
Discussions beyond the initial letter and response will not be published. Letters pertaining to published Discussions of articles will also not be published. Letters to the Editor are peer reviewed by a confidential panel; decisions are based upon their aggregated comments and suggestions, private comments to the Editor-in-Chief or designate, and recommendations of this panel. Decisions are final. All Letters are published at the discretion of the Editor; acceptance is not guaranteed.
Letters to the Editor are designed to highlight salient points, provide alternative perspectives, or raise constructive concerns in a professional manner. Letters to the Editor should be collegial, constructive, and professional in tone and substance. Letters submitted should pose a specific question that clarifies a point that either was not made in the article or was unclear, and therefore a response from the corresponding author of the article is requested.
Letters to the Editor should not be considered as a vehicle for post-publication peer review. Acerbic, combative, or aggressive tone, language, or sub-text will not be allowed.
Letters to the Editor are not intended to correct or address mistakes or resolve allegations of publishing or ethical misconduct; such concerns should be emailed directly to the editorial office ([email protected]) and could result in an investigation via the COPE process or recommendation for further adjudication by the ASPS Ethics or Publications Committees.
Authors will be listed in the order in which they appear in the submission. References should be supplied, where applicable, in standard format according to the instruction for authors. Letters should be submitted electronically via PRS Global Open’s Editorial Manager, at https://www.editorialmanager.com/gox.
We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and assignees to publish it in PRS Global Open and in any other form or medium.
The views, opinions, and conclusions expressed in Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the American Society of Plastic Surgeons. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.
GUIDELINES FOR EDITORIALS
The “Editorial” article type is reserved for the Editor-in-Chief, Co-editors and any Editorial Board Member of PRS Global Open. An alternative article type for non-Editorial Board Members would be “Viewpoint.” Editorials should not exceed 1,000 words, 2 figures and 5 references. Editorials are subject to peer review; acceptance is not guaranteed.
VIDEO: We encourage submission of videos with manuscripts.
All video files should be submitted as .mp4. If you have any questions, contact the editorial office.
All video files must be under 100 MB.
Some “stand alone” videos will be published online in the Video Gallery, at the Editor’s discretion. Narrated videos are preferred. Please make obvious notes on the cover letter and in the details section of your manuscript, as well as in the manuscript’s legend and body, that you are submitting video in conjunction with your article.
Videos must be submitted in their final form. They will not be edited in any capacity before publishing.
Supplemental Digital Content (SDC): Authors may submit SDC via Editorial Manager to LWW journals that enhance their article’s text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
SDC & Video Call-outs
Supplemental Digital Content and Videos must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as “Supplemental Digital Content,” include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.
Example: Supplemental Digital Content 1.mp4
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
Number of Figures allowed
Articles can contain no more than 20 figures or figure pieces due to page constraints. Please see above to find the figure limit for your article type.
NOTE: Each panel of a multi-panel figure is counted as a "figure piece."
NOTE: Each video clip will count against the figure piece allotment.
There is no charge to authors for color.
- Authors are strongly encouraged to submit all figures in color, when appropriate. Authors who submit black and white figures may be requested to supply color replacement figures.
- All immunohistochemistry slides and all pathology slides must be submitted in color. If such figures are submitted in black and white, authors will be requested to supply color replacement figures.
- All figures need to be of the highest quality possible. Elements of quality figures include:
- Color images, wherever possible and appropriate
- Correct focus
- Sufficient brightness and exposure for photographs
- Sufficient detail for close-up photographs
- Color correct images
- Figures of sufficient size (see below)
- Correct digital format
- Appropriate and consistent pre- and postoperative comparisons.
Authors will be requested to supply high quality replacement figures for figures that do not meet these criteria. Manuscripts submitted with poor quality or improperly prepared figures will not be reviewed until the concerns with the figures are corrected.
- Images should be saved laid out the way the author wishes them to be printed. For examples of appropriate layout, please consult the printed Journal.
- Multi-piece images (e.g., Fig. 1a, 1b, 1c) should be saved as one digital image ONLY AS A GUIDE. We still require the original high-quality images for publication. Figure labels ("a, b, c") should not appear on the figures.
- The minimum size at which figures should be submitted, is at a width of 6 2/3 INCHES (TWO "LANDSCAPES" OR THREE "PORTRAITS" ACROSS), 5 INCHES (TWO "PORTRAITS" ACROSS), OR 3 1/6 INCHES (FOR A FIGURE THAT WILL BE PLACED IN ONE COLUMN). NOTE: FIGURES SMALLER THAN THIS WILL BE RETURNED TO AUTHORS IN ORDER FOR THEM TO PROVIDE LARGER FIGURES.
- We can reduce the size of any figure as may be necessary, but most figures cannot be enlarged without an unacceptable loss of quality. When in doubt, therefore, submit a figure that is too large rather than too small.
- No photographs, digital or otherwise, should be substantively modified.
- The color mode for digital art must be changed from "rgb" to "cmyk," and the dpi or pixels/inch must be at least 300. (For more information about digital artwork guidelines, please visit our printer's web site at: http://cpc.cadmus.com/da.)
- Illustrations should be labeled clearly. Illustrations should be arranged symmetrically, in either "portrait" or "landscape" orientation. Before-and-after photographs should be identical in terms of size, position, and lighting. All illustrations must be accompanied by figure legends, to be attached at the end of the typewritten manuscript.
- Bar graphs with various shades of black do not reproduce well. Please submit them in color.
- To indicate scale on a photomicrograph, it is much better to include a scale bar as part of the figure, rather than to state the original magnification in the legend.
- Remember to check spelling on figures and in tables as well as in the main text.
Creating Digital Artwork
- Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42
- Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
- Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
Digital Artwork Guideline Checklist
The basics to have in place before submitting your digital art to PRS are delineated:
- Artwork should be saved as TIFF, PDF, Word Doc, PPT, or EPS files.
- Artwork is created as the actual size (or slightly larger) it will appear in the journal. (To get an idea of the size images should be when they print, study a copy of the journal to which you wish to submit. Measure the artwork typically shown and scale your image to match.)
- Crop out any white or black space surrounding the image.
- Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If the art is created in an MS Office program, convert to a hi-res PDF. If the PDF creation process is unfamiliar then submit the MS Office doc.
- Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
- Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
- Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
- Cite figures consecutively in your manuscript.
- Number figures in the figure legend in the order in which they are discussed.
- Upload figures consecutively to the Editorial Manager web site and number figures consecutively in the Description box during upload.
NOTE: Additional instructions for the Journal’s policies on Supplements, CME articles, Discussions, Clinical Follow-up articles, references, and on-line enhancements and videos are available at the Journal’s web site, www.PRSGlobalOpen.com.
THE PEER REVIEW PROCESS
The peer review process is handled entirely electronically via PRS Global Open’s Editorial Manager. Peer reviewers are instructed to review the contents of the submission in a critical, unbiased, and timely fashion. They review all pieces of the submission, including the manuscript itself as well as videos, tables, and images.
All Tier 1 submissions, some and Tier 2 submissions (namely Ideas and Innovations papers), and all Tier 4 articles (Video) to PRS Global Open (whether direct or transfer from PRS) are peer reviewed by at least one member of the PRS Global Open Editorial Board and at least one additional reviewer, who may or may not be an Editorial Board member of our sister publication, PRS, or a member of the peer review pool for both journals. Typically, Tier 1 articles are peer reviewed by no fewer than 3 reviewers.
Case Reports (Tier 2) are typically peer reviewed by one member of the PRS Global Open Editorial Board or a member of the peer review pool for both journals.
Tier 3 articles (Letters, Replies, Editorials, and Viewpoints) are internally reviewed by the Editor-in-Chief and sent out for peer-review if needed.
Tier 4 articles (Video) are peer reviewed. See above.
The Editor-in-Chief is excluded from managing the peer review process for any manuscript that includes the Editor-in-Chief as an author or otherwise comes from his institution. The Co-Editor performs the necessary duties in these instances.
Authors may suggest reviewers for their manuscripts, but there is no guarantee that the Editor-in-Chief will select any to serve on the review panel.
PRS Global Open currently utilizes the single-blind method of peer reviewing.
Cascading Peer Review
Plastic and Reconstructive Surgery- the sister journal to PRS Global Open- utilizes a ‘cascading peer review method’ whereby manuscripts not acceptable for PRS, but deemed suitable for PRS Global Open will automatically be considered for publication in PRS Global Open. Authors of such manuscripts will receive an email indicating the decision to not accept the article in PRS and an offer to automatically transfer the manuscript to the PRS Global Open editorial system. Authors will be able to click a link to ‘accept’ or ‘decline’ this offer; If ‘accept’ is clicked, the article will be automatically transferred and resubmitted to PRS Global Open’s Editorial Manager (www.editorialmanager.com/gox).
THE EDITORIAL PROCESS
To better help authors visualize the editorial process and track the status of their submission based on the system-generated “Editorial Status,” which can be checked from the author main menu, please view this simplified graphic demonstrating the editorial process and editorial status progression.
Specific questions about the status of a manuscript should be directed to the Editorial Staff at [email protected].
How to Submit a Paper to Plastic and Reconstructive Surgery – Global Open
—Tips for Success—
Preparation of the Experimental or Clinical Study—Before the Study Begins
- Clearly state the hypothesis/question to be investigated
- Determine a specific goal or purpose for the study
- Develop in advance a logical plan and design for conducting the study
- Consult biostatisticians in advance to determine what statistical tests and protocols are important to use
- Obtain appropriate ethical approval/IRB approval
- Register clinical trial at appropriate national or international trial registry
- Obtain a sufficiently large patient population
- Develop and implement proper controls
- Obtain adequate follow-up (6 months is minimum; 2+ years is ideal)
Writing the Manuscript
- Clearly state the research question/hypothesis
- Clearly state the study design
- Clearly state inclusion/exclusion criteria
- Report patient characteristics
- Assess for patient similarities and/or differences (if comparing groups)
- Identify any confounding issues and how they are taken into account during the study analysis
- Thoroughly describe the technique being evaluated (if conducing a therapeutic or diagnostic study)
- Define outcome measures (primary, secondary endpoints)
- Describe statistical methods used
- Report loss to follow-up
- Report on characteristics of patients no longer in study
- Report results for baseline data, and for all pre-defined time points throughout study
- Develop conclusions based on study results
- All cohort or comparative studies should clearly state whether the study is prospective or retrospective
- All case-control study designs should describe how the exposure and outcomes were measured in each group
- All case series articles should state if participants were enrolled consecutively
- All diagnostic studies should:
- Describe the reference (or "gold") standard
- Describe index test
- Report if outcome assessor was blinded to the results of both the index and reference test
- Report in what order the index and reference test was given
- Report time interval between index and reference test
- Disclosure all conflicts of interest
- Identify methods used to manage or minimize any conflicts of interest
Additional Keys to Successful Manuscript Submission
- Read and follow the instructions in the "Information for Authors"
- Read similar articles that have been published on the topic
- Have a native English speaker read and edit the manuscript prior to submission
- Read the article "Plagiarism and Dual Publication: Review of the Issues and Policy Statement" (PRS 2009;124:1333-1339)
- Read the article "Authorship and Medical Ghostwriting: Plastic and Reconstructive Surgery Policy" (PRS 2011;127:2496-2500)
- Excellent color figures and illustrations
- Sharp, clear focus
- Large file size for high quality print reproduction
- Sufficient brightness and exposure
- Close-up images sufficiently close to provide detail
- Appropriate, consistent long-term preoperative and postoperative comparisons
- Adequate literature review
- High quality surgical videos (narrated)
Top Reasons Why Manuscripts are Rejected
- Lack of scientific rigor
- Poor methodology/statistical analysis
- Very Small patient population
- Extremely Short patient follow-up
- Poor grammar/usage of proper English
- Lack of color figures/poor quality figures
English Language Assistance
Authors who are not native speakers of English who submit manuscripts to international journals often receive negative comments from referees or editors about the English–language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we encourage authors to consider seeking English-language revision assistance. There are many sources authors can turn to for such assistance, including partnering with a native English-speaking co-author and hiring third party author services firms. There are many firms authors can turn to; PRS Global Open does not recommend one firm over another, however we can confirm that Wolters Kluwer Author Services* is a trustworthy service provider.
Wolters Kluwer Author Services
Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript:
- Premium Editing: Intensive language and structural editing of academic papers to increase chances of journal acceptance.
- Advanced Editing: A complete language, grammar, and terminology check to give you a publication-ready manuscript.
- Translation with Editing: Write your paper in your native language and Wolters Kluwer Author Services will translate it into English, as well as edit it to ensure that it meets international publication standards.
- Plagiarism Check: Helps ensure that your manuscript contains no instances of unintentional plagiarism.
- Artwork Preparation: Save precious time and effort by ensuring that your artwork is viewed favorably by the journal without you having to incur the additional cost of purchasing special graphics software.
For more information regarding Wolters Kluwer Author Services, please visit http://wkauthorservices.editage.com.
*Note that the use of such a service is at the author's own expense and risk, and does not guarantee that the article will be accepted.
MANUSCRIPT PREPARATION AUTHOR CHECKLIST
Copy this form or download from http://www.PRSGlobalOpen.com and www.editorialmanager.com/gox. Use this checklist to help you include all required elements. Please complete the checklist and submit it with your manuscript.
- Prepare manuscript following Instructions for Authors
- Prepare all files necessary for submitting on Editorial Manager
- Cover letter to Editor with address, phone #, and/or e-mail address of corresponding author
- Title page, including
- Complete title of article (As per journal style, the recommended length of an article title should be no longer than 16 words, and preferably under 14.)
- List of authors, including first names and highest academic degrees. Author names should be given exactly as they should appear in the article.
- All authors’ affiliation(s) and full financial disclosures listed
- A footnote listing date(s) and site(s) of presentation (if applicable)
- Name and address of corresponding author
- Listing of each author's role/participation in the authorship of the manuscript on the manuscript (on a separate page in the manuscript)
- Statement of IRB Approval and/or statement of conforming to Helsinki Declaration
- Clinical Trial Registration information provided:
- Name of Trial database registered__________________________
- Registration Number and date registered________________________
- Structured abstract for original articles
- Summary for Case Reports and Ideas and Innovations
- List of references
- List of figure legends, including credit lines
- Copies of signed patient release forms for the use of all photographs in which patients can be identified. Forms can be found at: www.editorialmanager.com/gox
- Tables, including credit lines
- High quality color figures, properly prepared according to the above guidelines
- Video files are under 100 MB and prepared according to the above guidelines
Any manuscript that does not include this completed checklist or is missing essential elements may be returned to the corresponding author for additional information.